MediciNova, Inc.
MNOV
$1.79
$0.042.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 240.56% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 240.56% | -- | -- | -- | -- |
| Cost of Revenue | 20.98% | -- | -- | -- | -- |
| Gross Profit | 1,636.61% | -- | -- | -- | -- |
| SG&A Expenses | 27.36% | 16.69% | 21.73% | 24.58% | 2.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.83% | -5.61% | 1.90% | 5.90% | 22.82% |
| Operating Income | 29.55% | 11.45% | 2.87% | -2.17% | -18.40% |
| Income Before Tax | 29.47% | 9.70% | 0.46% | -6.95% | -24.85% |
| Income Tax Expenses | -- | -- | 9.09% | -- | -- |
| Earnings from Continuing Operations | 29.47% | 9.70% | 0.44% | -6.95% | -24.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.47% | 9.70% | 0.44% | -6.95% | -24.85% |
| EBIT | 29.55% | 11.45% | 2.87% | -2.17% | -18.40% |
| EBITDA | 29.59% | 11.44% | 2.85% | -2.17% | -18.44% |
| EPS Basic | 29.75% | 9.79% | 0.52% | -6.87% | -24.81% |
| Normalized Basic EPS | 29.67% | 9.89% | 0.56% | -7.16% | -24.78% |
| EPS Diluted | 29.75% | 9.79% | 0.52% | -6.87% | -24.81% |
| Normalized Diluted EPS | 29.67% | 9.89% | 0.56% | -7.16% | -24.78% |
| Average Basic Shares Outstanding | 0.36% | 0.00% | 0.14% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.36% | 0.00% | 0.14% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |